Kurna Sevda Aydin, Sengor Tomris, Garli Murat
Department of Ophthalmology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Private Practice, Istanbul, Turkey.
North Clin Istanb. 2021 Oct 19;8(5):479-484. doi: 10.14744/nci.2021.64624. eCollection 2021.
Our aim was to evaluate the long-term results of Ritleng bicanalicular silicone intubation for congenital and adult partially acquired nasolacrimal duct (NLD) obstruction.
We evaluated 28 eyes of the 26 patients treated with lacrimal intubation with the Ritleng method retrospectively. Patients were divided into two groups. Patients with congenital NLD obstruction (n: 16) constituted Group 1 and patients with adult partially acquired NLD obstruction (n: 10) constituted Group 2. The Ritleng probe was inserted from the canaliculus into the inferior meatus. Success was defined within two parameters: (1) Intubation of the silicone tube without complications and (2) recovery of the previous signs and symptoms and a normal fluorescein dye test.
Mean of the patients' ages was 2.4±1.6 years in Group 1 and 49±15 years in Group 2. The intubation was successful in all of the patients (100%) in Group 1, meanwhile in Group 2, false passage was observed in 2 patients (20%). Silicone tube was removed through the punctum in outpatient clinic conditions between 2 weeks and 3 months (mean: 2.1 months) in Group 1 and 4-6 months (mean: 5.2 months) in Group 2. Patients in Groups 1 and 2 were followed for 26±18.6-36±25 months, respectively. Previous signs and symptoms were recovered in 75% of the patients in Group 1 and the dye tests of these patients were normal. In Group 2, only two patient's symptoms were resolved (20%). For the adult patients whose symptoms were not resolved, an external dacryocystorhinostomy operation was performed.
The Ritleng lacrimal intubation system is an effective procedure for the treatment of congenital NLD obstruction for both short and long term. On the other hand, the effectiveness of the procedure is limited for the adult partially acquired NLD obstruction.
我们的目的是评估Ritleng双泪小管硅胶插管术治疗先天性及成人部分获得性鼻泪管阻塞的长期效果。
我们回顾性评估了26例接受泪道插管Ritleng法治疗的患者的28只眼。患者分为两组。先天性鼻泪管阻塞患者(n = 16)为第1组,成人部分获得性鼻泪管阻塞患者(n = 10)为第2组。将Ritleng探针从泪小管插入下鼻道。成功定义为两个参数:(1)硅胶管插管无并发症;(2)先前的体征和症状恢复且荧光素染料试验正常。
第1组患者平均年龄为2.4±1.6岁,第2组为49±15岁。第1组所有患者(100%)插管成功,而第2组有2例患者(20%)出现假道。第1组硅胶管在门诊条件下于2周和3个月之间(平均:2.1个月)经泪点取出,第2组在4 - 6个月(平均:5.2个月)取出。第1组和第2组患者分别随访26±18.6至36±25个月。第1组75%的患者先前的体征和症状恢复,这些患者的染料试验正常。第2组只有2例患者症状得到缓解(20%)。对于症状未缓解的成年患者,进行了外路泪囊鼻腔吻合术。
Ritleng泪道插管系统是治疗先天性鼻泪管阻塞短期和长期均有效的方法。另一方面,该方法对成人部分获得性鼻泪管阻塞的有效性有限。